Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Breast Cancer
Interventions
GENETIC

Single nucleotide polymorphism (SNP)

Evaluating SNP association with traits.

OTHER

high performance liquid chromatography

analysis of plasma concentrations of drugs

OTHER

measurements by DXA

determine bone mineral density (BMD)

OTHER

questionnaire administration

determine attitude changes

Trial Locations (4)

32224

Mayo Clinic in Florida, Jacksonville

55905

Mayo Clinic, Rochester

85259-5499

Mayo Clinic in Arizona, Scottsdale

77030-4009

M. D. Anderson Cancer Center at University of Texas, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER